Treatment of Vascular Ehlers-Danlos Syndrome A Systematic Review

被引:70
|
作者
Bergqvist, David [1 ]
Bjorck, Martin [1 ]
Wanhainen, Anders [1 ]
机构
[1] Uppsala Univ, Dept Surg Sci, Vasc Surg Sect, SE-75185 Uppsala, Sweden
关键词
EDS IV; surgery; systematic review; Vascular Ehlers-Danlos Syndrome; SYNDROME TYPE-IV; CAROTID-CAVERNOUS FISTULA; OF-THE-LITERATURE; SPONTANEOUS RUPTURE; ENDOVASCULAR TREATMENT; SURGICAL COMPLICATIONS; ARTERY PSEUDOANEURYSM; MYOCARDIAL-INFARCTION; SUBCLAVIAN ARTERY; PATIENT;
D O I
10.1097/SLA.0b013e31829c7a59
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To provide the collected evidence from all literature reports. Background: Vascular Ehlers-Danlos syndrome (EDS) is a rare connective tissue disorder with serious hemorrhagic consequences. Most experience on treatment is based on case reports and small case series. Method: A systematic literature review was performed. PubMed and reference lists were scrutinized. Results: A total of 231 patients were identified with no gender preponderance. Aneurysms were present in 40%, often multiple. In 33%, there was an arterial rupture without an underlying aneurysm. Carotidocavernous fistula was seen in 18%. After open surgery the mortality was 30%; after endovascular procedures, it was 24%; in a group of miscellaneous cases, it was 60%; and the overall mortality was 39%. The median age of patients at death was 31 years. The median follow-up time was 12 months (5 days-7 years), but in 20% cases, it was not reported. In only 29 of the 119 recent patients (24%) the mutation was verified with molecular genetic testing. Conclusions: Vascular EDS is a serious disorder with high mortality, which does not seem to have been influenced by new treatment methods. Invasive methods should be used only when necessary, primarily to save the patients' life. Whenever possible, the genetic molecular defect should be identified. The results of this review may be affected by publications bias. Ideally, a prospective registry should be created.
引用
收藏
页码:257 / 261
页数:5
相关论文
共 50 条
  • [41] EHLERS-DANLOS SYNDROME
    PASCHER, F
    KANOF, A
    AMA ARCHIVES OF DERMATOLOGY AND SYPHILOLOGY, 1953, 67 (02): : 214 - 217
  • [42] Ehlers-Danlos syndrome
    G. Atkinson
    British Dental Journal, 2020, 229 : 153 - 153
  • [43] EHLERS-DANLOS SYNDROME
    JONES, EW
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1957, 50 (12): : 1021 - 1021
  • [44] THE EHLERS-DANLOS SYNDROME
    BOCHKOVA, DN
    TERNOVA, TI
    KOSTIKOV, MV
    FEDOROV, AM
    TERAPEVTICHESKII ARKHIV, 1985, 57 (04) : 140 - 143
  • [45] EHLERS-DANLOS SYNDROME
    BANNERMAN, RM
    GRAF, CJ
    UPSON, JF
    BMJ-BRITISH MEDICAL JOURNAL, 1967, 3 (5564): : 558 - +
  • [46] Ehlers-Danlos syndrome
    Hamel, BCJ
    NETHERLANDS JOURNAL OF MEDICINE, 2004, 62 (05): : 140 - 142
  • [47] EHLERS-DANLOS SYNDROME
    GERICKE, GS
    MARITZ, F
    RETIEF, AE
    VANNIEKERK, WA
    SOUTH AFRICAN MEDICAL JOURNAL, 1975, 49 (11): : 385 - 385
  • [48] THE EHLERS-DANLOS SYNDROME
    HOLT, JF
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1946, 55 (04) : 420 - 426
  • [49] EHLERS-DANLOS SYNDROME
    BEIGHTON, P
    ANNALS OF THE RHEUMATIC DISEASES, 1970, 29 (03) : 332 - +
  • [50] EHLERS-DANLOS SYNDROME
    EDGREN, G
    ACTA PAEDIATRICA SCANDINAVICA, 1962, 51 (02): : 232 - +